Heart failure & cardiomyopathiesCohort study
Prognostic impact of pericardial effusion in patients with acute myocarditis
- observational ambispective cohort study
- based on the AMPHIBIA registry (Assistance Publique-Hôpitaux de Paris/ACTION Study Group)
Authors' conclusion
This study characterizes the phenotypes and outcomes of patients hospitalized for an AM, with and without pericardial effusion. Pericardial involvement was associated with LV dysfunction, immunological myocarditis, elevated CRP, and fever and was linked to a markedly higher risk of the composite outcome, remaining an independent predictor of adverse events. Differentiating these two phenotypes may provide physicians with valuable guidance for managing therapy in these patients.
Study context
- Population
- Patients hospitalized for proven acute myocarditis (AM) between August 2008 and December 2024 at La Pitié Salpêtrière Hospital, Paris, Francepatients with AM, follow-up 3.7 (1.3–7.3) years · with pericardial effusion 134 · without pericardial effusion 447
- Participants
- 581 patients
- Exposure
- Patients with vs without pericardial effusion
- pericardial effusionn = 134
- without pericardial effusionn = 447reference
- Outcome
- Main composite outcome:
- All-cause death
- Temporary mechanical circulatory support
- Severe ventricular arrhythmia
- Heart transplantation
- Follow-up
- At the longest , up to 7 years
Main finding
As reported in the abstract
Observational data: associations, not effects.
Further findings
Independent variables associated with pericardial effusion at admission
- left ventricular (LV) dysfunction, immunological myocarditis, elevated CRP, and fever
Original publication
Summarised from the published abstract; every number is checked against it